Wegener's granulomatosis

Free

E-Newsletters

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Complications

By Mayo Clinic staff

Besides affecting your upper and lower respiratory tracts, Wegener's granulomatosis may affect other organs, including your skin, eyes, ears, kidneys, spinal cord and heart. Complications may include:

  • Hearing loss. Inflammation of granulated tissue in the middle ear can lead to hearing loss.
  • Skin scarring. Sores may develop and may lead to severe scarring.
  • Heart attack. Wegener's granulomatosis can affect the arteries of your heart, resulting in chest pain or a heart attack.
  • Kidney (renal) damage. As Wegener's granulomatosis progresses, it's likely to affect your kidneys. It can lead to glomerulonephritis, a type of kidney disease that hampers your kidneys' ability to remove waste and excess fluid from your body, leading to a buildup of waste products in your bloodstream (uremia). Kidney failure is a leading cause of death from Wegener's granulomatosis.
References
  1. Wegener's granulomatosis. The Merck Manuals: The Merck Manual for Healthcare Professionals. http://www.merck.com/mmpe/sec04/ch033/ch033k.html#sec04-ch033-ch033k-362. Accessed July 26, 2010.
  2. Wegener's granulomatosis. National Institute of Allergy and Infectious Diseases. http://www.niaid.nih.gov/topics/wegeners/Pages/Default.aspx. Accessed July 26, 2010.
  3. Hellmann DB, et al. Musculoskeletal and immunologic disorders. In: McPhee SJ, et al. Current Medical Diagnosis and Treatment 2010. 49th ed. New York, N.Y.: McGraw Hill; 2010. http://www.accessmedicine.com/content.aspx?aID=10083. Accessed July 30, 2010.
  4. Langford CA, et al. The vasculitis syndromes. In: Fauci AS, et al. Harrison's Principles of Internal Medicine. 17th ed. New York, N.Y.: McGraw Hill; 2008. http://www.accessmedicine.com/content.aspx?aID=2859426. Accessed July 30, 2010.
  5. King TE, et al. Clinical manifestations and diagnosis of Wegener's granulomatosis and microscopic polyangiitis. http://www.uptodate.com/home/index.html. Accessed July 26, 2010.
  6. Stone JH, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. New England Journal of Medicine. 2010;363:221.
  7. Turnball J, et al. Adverse effects of therapy for ANCA-associated vasculitis. Best Practice and Research Clinical Rheumatology. 2009;23:391.
  8. Rosenow E (expert opinion). Mayo Clinic, Rochester, Minn. Aug. 3, 2010.
DS00833 Sept. 25, 2010

© 1998-2012 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Print Share Reprints

Advertisement


Text Size: smaller largerlarger